Login / Signup
Kelena Klippel
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 2
Top Topics
Clinical Trial
Brain Metastases
Protein Kinase
Acute Lymphoblastic Leukemia
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Christina A von Roemeling
,
Bently P Doonan
,
Kelena Klippel
,
Daniel C Schultz
,
Lan Hoang-Minh
,
Vrunda Trivedi
,
Chenglong Li
,
Rylynn Russell
,
Siva Rama Raju Kanumuri
,
Abhisheak Sharma
,
Han W Tun
,
Duane A Mitchell
Oral IRAK-4 inhibitor CA-4948 is blood-brain barrier penetrant and has single-agent activity against CNS lymphoma and melanoma brain metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)
Christina A von Roemeling
,
Bently P Doonan
,
Kelena Klippel
,
Daniel C Schultz
,
Lan Hoang-Minh
,
Vrunda Trivedi
,
Chenglong Li
,
Rylynn Russell
,
Siva Rama Raju Kanumuri
,
Abhisheak Sharma
,
Han W Tun
,
Duane A Mitchell
Oral IRAK-4 inhibitor CA-4948 is blood-brain barrier penetrant and has single-agent activity against CNS lymphoma and melanoma brain metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)